MUC4, mutated in 11.36% and 10% of our rNEN-S and rNEN-L subjects, has also been revealed to be aberrantly expressed in a variety of epithelial carcinomas and can serve as a clinical tool for cancer diagnosis and prognosis [51]. The gene discussed is MUC4; the disease is carcinoma.